In the last trading session, 12.98 million Achieve Life Sciences Inc (NASDAQ:ACHV) shares changed hands as the company’s beta touched 1.63. With the company’s per share price at $2.23 changed hands at -$1.28 or -36.47% during last session, the market valuation stood at $77.35M. ACHV’s last price was a discount, traded about -138.12% off its 52-week high of $5.31. The share price had its 52-week low at $1.84, which suggests the last value was 17.49% up since then. When we look at Achieve Life Sciences Inc’s average trading volume, we note the 10-day average is 1.61 million shares, with the 3-month average coming to 262.38K.
Analysts gave the Achieve Life Sciences Inc (ACHV) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ACHV as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Achieve Life Sciences Inc (NASDAQ:ACHV) trade information
Instantly ACHV was in red as seen at the end of in last trading. With action -33.43%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -51.94%, with the 5-day performance at -33.43% in the red. However, in the 30-day time frame, Achieve Life Sciences Inc (NASDAQ:ACHV) is -29.21% down. Looking at the short shares, we see there were 2.97 million shares sold at short interest cover period of 9.04 days.
The consensus price target for the stock as assigned by Wall Street analysts is 4.75, meaning bulls need an upside of 53.05% from its current market value. According to analyst projections, ACHV’s forecast low is 4 with 5.5 as the target high. To hit the forecast high, the stock’s price needs a -146.64% plunge from its current level, while the stock would need to soar -79.37% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 50.01%. The 2025 estimates are for Achieve Life Sciences Inc earnings to decrease by -1.48%.
ACHV Dividends
Achieve Life Sciences Inc is expected to release its next quarterly earnings report on 2025-May-13.
Achieve Life Sciences Inc (NASDAQ:ACHV)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.69% of Achieve Life Sciences Inc shares while 41.59% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 46.05%. There are 41.59% institutions holding the Achieve Life Sciences Inc stock share, with FRANKLIN RESOURCES INC the top institutional holder. As of 2024-06-30, the company held 17.6358% of the shares, roughly 6.05 million ACHV shares worth $19.6 million.
PROPEL BIO MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 7.148% or 2.45 million shares worth $11.53 million as of 2024-06-30.
